Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet productionMei Chang, MS Cairo, Violet Shen et al.|Blood|1996Cited by 109
A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonatesMitchell S. Cairo, Avroy A. Fanaroff, Jan M. Agosti et al.|The Journal of Pediatrics|1999Cited by 74
Phase I/II dose escalation study of recombinant human interleukin‐11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study*Mitchell S. Cairo, Gregory H. Reaman, Virginia Davenport et al.|British Journal of Haematology|2004Cited by 32
Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC)Ilse Houtenbos, MS Cairo, Francisco Bracho et al.|Bone Marrow Transplantation|2001Cited by 20
A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities.Francisco Bracho, Mitchell S. Cairo, Mark Krailo et al.|PubMed|2001Cited by 17